Biosyntia gets a capital injection of €11.5M to launch world’s first bio-based vitamin B7
Biosyntia, a Copenhagen-based industrial biotech company, announced that it has raised €11.5M in a Series B funding round from experienced venture capital investors.
The round was closed with an